Company: TVRD
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001104659-25-054853
Chunk: 232

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 232
---
 of any advisory vote on executive compensation; |

| ● | reviewing and making recommendations to the Board related to management succession; |

134

| ● | establishing, approving, modifying and overseeing our compensation clawback or similar policies and any required recoupment disclosures; and |

| ● | overseeing risk management of our compensation policies and practices on at least an annual basis and considering whether risk arising from our compensation policies and practices are reasonably likely to have a material adverse risk on the Company. |

The members of the compensation committee are Sujal Shah, Wallace Hall and Susan Shiff. Sujal Shah is the chair of the compensation committee. Each member of our compensation committee is a “non-employee” director within the meaning of Rule 16b-3 of the rules promulgated under the Exchange Act and independent within the meaning of the independent director guidelines of Nasdaq. The composition of the compensation committee complies with the applicable requirements of the rules and regulations of Nasdaq. Nominating and Corporate Governance Committee The nominating and corporate governance committee is responsible for overseeing our corporate governance functions on behalf of the Board, including:

| ● | identifying, reviewing, and evaluating candidates to serve on the Board consistent with criteria approved by the Board, including consideration of the potential conflicts of interest and applicable independence and other requirements; |

| ● | recommending candidates to serve as nominee for director for the annual meeting of the stockholders; |

| ● | reviewing the performance of the Board and management and making recommendations to the Board for areas for improvement; |

| ● | overseeing the Board committee structure and operations and making recommendations to the Board regarding the membership of the committees of the Board; and |

| ● | developing, reviewing and assessing, and overseeing and monitoring compliance with, our corporate governance guidelines and the Code of Business Conduct and Ethics. |

The members of the nominating and corporate governance committee are Cynthia Smith, Shaheen Wirk and Susan Shiff. Cynthia Smith is the chair of the nominating and corporate governance committee. The composition of the nominating and corporate governance committee meets the requirements for independence under, and complies with, any applicable requirements of the rules and regulations of Nasdaq.

135

EXECUTIVE COMPENSATION To achieve our goals, we have designed our compensation and benefits program to attract, retain, incentivize and reward deeply talented and qualified executives who share our philosophy and desire to work towards achieving these goals. We believe our compensation program should promote the success of the Company and align executive incentives with the long-term interests of our stock